01 2Apicore Pharmaceuticals Private Limited
02 1DARMERICA, LLC
03 1Galenova Inc
04 1Industriale Chimica s.r.l.
05 1KALCHEM INTERNATIONAL INC
06 1LETCO MEDICAL, LLC
07 1Pharma Source Direct, Inc.
08 1Professional Compounding Centers of America
09 1Professional Compounding Centers of America dba PCCA
10 1QINGDAO TIDA BIOTEK CO.,LTD
11 1Qingdao Biopeptek Co., Ltd.
12 1RAKSHIT DRUGS PRIVATE LIMITED
13 1Reliable Biopharmaceutical LLC
14 1Spectrum Laboratory Products, Inc.
01 5PHENTOLAMINE MESYLATE
02 10Phentolamine Mesylate
01 1Canada
02 1China
03 3India
04 1Italy
05 7U.S.A
06 2United Kingdom
NDC Package Code : 42973-194
Start Marketing Date : 2012-09-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 42973-389
Start Marketing Date : 2024-04-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : INJECTION, POWDER, FOR SOLUTION (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 71052-285
Start Marketing Date : 2019-08-16
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 63190-0090
Start Marketing Date : 2003-02-13
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 60592-602
Start Marketing Date : 2023-10-16
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 62991-1108
Start Marketing Date : 2010-08-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51927-0176
Start Marketing Date : 2018-09-24
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 51927-2669
Start Marketing Date : 2013-06-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 59605-2260
Start Marketing Date : 1996-12-11
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 49452-5217
Start Marketing Date : 1997-12-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
A Phentolamine Mesylate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Phentolamine Mesylate, including repackagers and relabelers. The FDA regulates Phentolamine Mesylate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Phentolamine Mesylate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Phentolamine Mesylate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Phentolamine Mesylate supplier is an individual or a company that provides Phentolamine Mesylate active pharmaceutical ingredient (API) or Phentolamine Mesylate finished formulations upon request. The Phentolamine Mesylate suppliers may include Phentolamine Mesylate API manufacturers, exporters, distributors and traders.
click here to find a list of Phentolamine Mesylate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Phentolamine Mesylate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Phentolamine Mesylate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Phentolamine Mesylate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Phentolamine Mesylate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Phentolamine Mesylate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Phentolamine Mesylate suppliers with NDC on PharmaCompass.
We have 13 companies offering Phentolamine Mesylate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
